Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants.

ABSTRACT:

Background

Tobacco use (smoking) causes adverse clinical outcomes among patients with cancer, including increased cancer-related mortality. In participants in cancer clinical trials, the prevalence of tobacco use and the factors associated with tobacco use are not well described.

Methods

Data were examined from participants enrolled in SWOG cancer clinical treatment trials between 2016 and 2022 who reported their smoking status at trial enrollment. Baseline variables (smoking status, insurance type, zip code, and demographic factors) were obtained from patient registration forms. Bivariate and multivariable associations were examined via logistic regression.

Results

Among 4326 patients enrolled in 29 trials, 48.1% reported currently/previously smoking, including 12.4%

SUBMITTER: Presant CA 

PROVIDER: S-EPMC11834169 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature